S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Synergy Strips Corp. Acquires Assets of America’s No.1 Brain Health Supplement, FOCUSfactor (2015/1/26)|
|Synergy Pharmaceuticals Reports Third Quarter 2014 Financial Results (2014/11/10)|
|Synergy Pharmaceuticals Announces Positive Results of SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation (2014/11/19)|
|Allied-Bristol Life Sciences Forms Strategic Partnership with Synergy Partners R&D Solutions to Advance Biopharmaceutical Innovations From Leading U.S. Academic Research Institutions (2014/11/18)|
|Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (2014/12/18)|
|Synergy Pharmaceuticals Completes Patient Enrollment for the Second Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation (2015/1/29)|
|Synergy Pharmaceuticals Completes Patient Enrollment for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation (2015/1/8)|
|Synergy Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference (2014/11/5)|
|New Data From Evolve Clinical Program Demonstrate SYNERGY™ Bioabsobable Polymer Stent Meets Key Performance Endpoints (2014/11/19)|
|Karyopharm Presents Positive Combination Data for Selinexor (KPT-330) in Multiple Myeloma Patients at ASH 2014 Annual Meeting (2014/12/8)|
Click above to view more mutual fund data and stats for esyg - e-Synergies Inc.